Skip to main content


Members of the Division of Pediatric Endocrinology and Diabetology actively participate in numerous clinical and basic research studies, and division members successfully compete for both governmental and non-governmental research funding. The division participates in several national diabetes research consortiums, including Type 1 Diabetes TrialNet, DirecNet, the Type 1 Diabetes Exchange, and the Immune Tolerance Network.

Current clinical research interests include treatment of central precocious puberty, long-term outcomes of central precocious puberty, osteogenesis imperfecta, bone disease in children with cystic fibrosis, hypophosphatasia, congenital hypothyroidism, insulin pump usage in children with type 1 diabetes, endothelial progenitor cells in type 1 diabetes, continuous glucose monitoring in type 1 diabetes, immunomodulatory therapies to prevent or modify type 1 diabetes, quality of life in type 1 diabetes, long-term outcomes of growth hormone treatment, new agents for treatment of growth hormone deficiency, treatment of growth hormone deficiency, treatment of type 2 diabetes, and the relationship of sleep apnea to insulin resistance and obesity.

Get Research Updates

Research faculty throughout IU School of Medicine’s academic departments post updates about their work to the research updates blog. Stay up-to-date about medical research in pediatrics.

Visit the Blog

Wells Center for Diabetes Research

Wells Center for Pediatric Research

The Division of Pediatric Endocrinology and Diabetology includes the Center for Diabetes and Metabolism, which is designed to promote the training of scientists whose research will develop new understanding of the basis of diabetes and its complications and to cultivate basic science research that can speed the discovery of more effective therapies. Located in the IU School of Medicine Van Nuys Medical Science Building in Indianapolis, the Pediatric Diabetes Research team is working to understand the biology and molecular mechanisms that lead to the development of both type 1 and type 2 diabetes in children. This research team currently has four nationally recognized NIH-funded principal investigators whose research focuses on the development, function and survival of insulin-producing pancreatic islets. These investigators are supported by an outstanding team of researchers at multiple levels, including research faculty, postdoctoral fellows, graduate students and undergraduates.

Current areas of laboratory-based research include basic diabetes research, pancreatic islets, islet transplantation, pathophysiology of diabetes, molecular pathways, insulin-producing cells and stem cell therapies.